Weiss Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Weiss Asset Management's AXSM Position: Q3 2026 in Review
Weiss Asset Management sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 80,000 shares — an estimated $19.6M sold.
Weiss Asset Management first reported a position in AXSM in Q1 2019 and held it in 2 quarters. The position peaked at $19.6M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Weiss Asset Management reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- Weiss Asset Management sold 80,000 Axsome Therapeutics shares in Q3 2026, an estimated $19.6M.
- Weiss Asset Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 2 quarters.
- Weiss Asset Management's Axsome Therapeutics position peaked at $19.6M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Weiss Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.